← Leaderboards
Gulin Oz
University Of Minnesota
$11,194,752
Attributed
$21,251,812
Total exposure
24
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,251,812 · 24
By mechanism
R01$13,548,484 · 4
U01$6,148,541 · 1
R21$1,191,615 · 3
P41$287,005 · 11
M01$56,167 · 4
R13$20,000 · 1
Top collaborators
- Elizabeth R. Seaquist10 shared
- Tetsuo Ashizawa6 shared
- Kejal Kantarci6 shared
- Eva-Maria Ratai6 shared
- Alexandra Durr5 shared
- Thomas Klockgether5 shared
- Henry L Paulson5 shared
- Hayley Sarah Mcloughlin1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Jose Ricardo Suarez$7,637,697
- Maxim Chacko-Joseph Cheeran$2,079,355
Others in their field
Top investigators on “Magnetic Resonance Spectroscopy”
- Gregory S Boebinger · Florida State University$113,843,871
- Alex Lacerda · Florida State University$85,941,624
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$58,843,857
- John L Markley · University Of Wisconsin Madison$52,112,237
- Eric C Palm · Florida State University$31,951,397
- Stanley J Opella · Wistar Institute$30,798,621
Research focus
Magnetic Resonance SpectroscopyFundingMagnetic Resonance ImagingBiochemicalBrainNeurochemistryNerve DegenerationNeurodegenerative DisordersAtaxiaUnited States National Institutes Of HealthPathologySpinocerebellar AtaxiasAffectTechnologyInvestigationInstitutionResponseBiological MarkersCollaborationsClinicProtocols DocumentationSiteImageCerebellum
Grant awards (55)
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$620,430
R01 · FY2025 · NS · contact PI
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$615,261
R01 · FY2024 · NS · contact PI
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$638,887
R01 · FY2023 · NS · contact PI
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$449,809
R01 · FY2023 · NS · contact PI
Clinical Trial Readiness for SCA1 and SCA3$1,098,761
U01 · FY2022 · NS
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$644,224
R01 · FY2022 · NS · contact PI
Measurement of glucose homeostasis in human brain by NMR$546,937
R01 · FY2022 · NS
Supplementary funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (âREADISCAâ)$163,799
U01 · FY2022 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,220,506
U01 · FY2021 · NS
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$721,322
R01 · FY2021 · NS · contact PI
Measurement of glucose homeostasis in human brain by NMR$553,498
R01 · FY2021 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,221,189
U01 · FY2020 · NS
Measurement of glucose homeostasis in human brain by NMR$552,362
R01 · FY2020 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,183,360
U01 · FY2019 · NS
Partnership for Magnetic Resonance Spectroscopy Biomarker Development$596,367
R01 · FY2019 · NS · contact PI
Measurement of glucose homeostasis in human brain by NMR$549,014
R01 · FY2019 · NS
Defining Biomarkers for Spinocerebellar Ataxia Type 3$434,939
R21 · FY2019 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,260,926
U01 · FY2018 · NS
Partnership for Magnetic Resonance Spectroscopy Biomarker Development$613,674
R01 · FY2018 · NS · contact PI
Measurement of glucose homeostasis in human brain by NMR$543,821
R01 · FY2018 · NS
Partnership for Magnetic Resonance Spectroscopy Biomarker Development-Supplement$16,297
R01 · FY2018 · NS · contact PI
7th Ataxia Investigators Meeting, From Bench to Bedside: Entering a New Era of Ataxia Therapies$10,000
R13 · FY2018 · NS · contact PI
Partnership for Magnetic Resonance Spectroscopy Biomarker Development$652,535
R01 · FY2017 · NS · contact PI
7th Ataxia Investigators Meeting, From Bench to Bedside: Entering a New Era of Ataxia Therapies$10,000
R13 · FY2017 · NS · contact PI
Partnership for Magnetic Resonance Spectroscopy Biomarker Development$645,343
R01 · FY2016 · NS · contact PI
Partnership for Magnetic Resonance Spectroscopy Biomarker Development$690,619
R01 · FY2015 · NS · contact PI
Measurement of Glucose Homeostasis in Human Brain by NMR$349,604
R01 · FY2015 · NS
Measurement of Glucose Homeostasis in Human Brain by NMR$493,311
R01 · FY2014 · NS
Magnetic Resonance Spectroscopy Biomarkers of Neurodegeneration$320,918
R01 · FY2014 · NS · contact PI
Measurement of Glucose Homeostasis in Human Brain by NMR$460,878
R01 · FY2013 · NS
Magnetic Resonance Spectroscopy Biomarkers of Neurodegeneration$312,808
R01 · FY2013 · NS · contact PI
Measurement of Glucose Homeostasis in Human Brain by NMR$491,702
R01 · FY2012 · NS
Magnetic Resonance Spectroscopy Biomarkers of Neurodegeneration$324,146
R01 · FY2012 · NS · contact PI
Measurement of Glucose Homeostasis in Human Brain by NMR$478,758
R01 · FY2011 · NS
Magnetic Resonance Spectroscopy Biomarkers of Neurodegeneration$328,281
R01 · FY2011 · NS · contact PI
NONINVASIVE QUANTITATION OF BIOCHEM CHANGESPARKINSONS$22,692
P41 · FY2011 · RR · contact PI
NEUROCHEMICAL CORRELATES OF PATHOLOGY IN SPINOCEREBELLAR ATAXIAS$22,692
P41 · FY2011 · RR · contact PI
NON-INVASIVE QUANTITATION OF CELLU & BIOCHEM CHANGES IN SPINOCEREBELLAR ATAXIAS$22,692
P41 · FY2011 · RR · contact PI
Magnetic Resonance Spectroscopy Biomarkers of Neurodegeneration$337,678
R01 · FY2010 · NS · contact PI
NONINVASIVE QUANTITATION OF BIOCHEM CHANGESPARKINSONS$19,253
P41 · FY2010 · RR · contact PI
NEUROCHEMICAL CORRELATES OF PATHOLOGY IN SPINOCEREBELLAR ATAXIAS$19,253
P41 · FY2010 · RR · contact PI
NON-INVASIVE QUANTITATION OF CELLU & BIOCHEM CHANGES IN SPINOCEREBELLAR ATAXIAS$19,253
P41 · FY2010 · RR · contact PI
Non-Invasive Quantitation of Cellular and Biochemical Changes in Hereditary Ataxi$155,255
R21 · FY2009 · NS · contact PI
MAGNETIC RESONANCE SPECTROSCOPY IN ATAXIAS$38,055
M01 · FY2009 · RR · contact PI
MAGNETIC RESONANCE SPECTROSCOPY IN ATAXIAS$25,670
P41 · FY2009 · RR · contact PI
NONINVASIVE QUANTITATION OF BIOCHEM CHANGESPARKINSONS$25,670
P41 · FY2009 · RR · contact PI
NEUROCHEMICAL CORRELATES OF PATHOLOGY IN SPINOCEREBELLAR ATAXIAS$25,655
P41 · FY2009 · RR · contact PI
NON-INVASIVE QUANTITATION OF CELLU & BIOCHEM CHANGES IN SPINOCEREBELLAR ATAXIAS$12,835
P41 · FY2009 · RR · contact PI
Non-Invasive Quantitation of Cellular and Biochemical Changes in Hereditary Ataxi$190,296
R21 · FY2008 · NS · contact PI
Neurochemical Correlates of Pathology in Spinocerebellar Ataxias$186,875
R21 · FY2008 · NS · contact PI
DETECTION AND QUANTIFICATION OF BRAIN GLYCOGEN$71,340
P41 · FY2008 · RR · contact PI
MAGNETIC RESONANCE SPECTROSCOPY IN ATAXIAS$884
M01 · FY2008 · RR · contact PI
Neurochemical Correlates of Pathology in Spinocerebellar Ataxias$224,250
R21 · FY2007 · NS · contact PI
MAGNETIC RESONANCE SPECTROSCOPY IN ATAXIAS$8,978
M01 · FY2007 · RR · contact PI
MAGNETIC RESONANCE SPECTROSCOPY IN ATAXIAS$8,250
M01 · FY2006 · RR · contact PI